​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

  • ​The FY 2025 Fund Assessment is due on October 1, 2024, please visit the Fund Assessment page​ for more information.
  • The Prescription Drug Affordability Stakeholder Council Meeting will now take place on November 4, 2024. More information can be found here.
  • The Prescription Drug Affordability Board will be holding an Ad-Hoc meeting on October 28, 2024. More information can be found here​.

Join the Prescription Drug Affordability Board's Mailing List
Please  follow the instructions to register for the PDAB's Mailing List. This will allow you to keep up to date on the actions of the PDAB.​

Section2

Section3

Section5